IFPMA SE-Asia Ethics & Business Integrity Days

6 - 7 November 2019 Bangkok, Hotel The Sukosol, November 6-7, 2019

6 - 7 November 2019


09:00 to 17:30


Bangkok, Hotel The Sukosol, November 6-7, 2019


This event has now passed. To browse our upcoming events click here.

Following successful Code Capacity Workshops in locations such as Mexico City, Accra, Beijing, Dubai, Johannesburg and Manila, the global association of the research-based pharmaceutical industry (www.ifpma.org) has selected Bangkok to deliver a hands-on training on the recently launched revised Code of Practice and to engage in a broader discussion about the progress and the future of ethics & business integrity in Thailand and South-East Asia as a whole – with regional and international IFPMA experts.

This workshop is free of charge – all time and effort is donated by IFPMA and its member companies and associations.

Workshop capacity is limited and registration confirmation will be on a first-come first-served basis. Once registered, a space will be assigned to you. Therefore, please make sure you can come or let the organizers know so your place can be given to someone on the waiting list.

You can access the registration platform here


November 6 - 09:00 - 17:30

Hands-on Code Capacity Workshop

The workshop has been designed to provide “business case” exposure to participants on day to day topics including:
– How to properly interact with Healthcare Professionals (doctors, nurses, pharmacists etc.) for promotional and medical information sharing
– Increasing the level of ethical conduct of activities in your organization
– Insights on how to set up and run a successful compliance program in your organization
– Interactions with patient organizations
– Activities like commissioning and creation of promotional material and writing and approving copy and artwork.
– Determining promotional methods including professional representation, hospitality to doctors and the use of audio-visual and related communications technology in the organization of international educational events.

The workshop will be based on the new IFPMA Code of Practice (effective Jan 1, 2019) which forms the basis for national codes of practice within Thailand, South-East Asia and worldwide. Participants will receive an update on the Code and the respective interpretation – trainers are keen to engage and exchange with the audience on local implementation.

November 7 - 08:30 - 12:30

Good Governance in Drug Systems

The forum is designed to engage stakeholders to join forces to move ahead. The focus is on how trust in health authorities and healthcare professionals is paramount in implementing a fully efficient healthcare system.
Roundtable participants will address the progress Thailand has been making in raising its standards in the Ethics and Business Integrity space, which is contributing to IFPMA’s goal to create a level playing field in the Thailand market.

The session will be set up as a roundtable discussion with invited key stakeholders as discussants. Other participants are welcome as observers and can engage in the Q&A session.


Varintorn Piyanan Country Head of Ethics & Business Integrity Thailand & Myanmar, Sanofi-Aventis (Thailand) co., Ltd
Anattaya Chotivimut Compliance Assurance Lead - Asia, Japan, Australia & New Zealand, AstraZeneca (Thailand) Ltd.
Anchalee Anuchitanukul Head of Compliance for Pharma Division and Country Compliance Head - Novartis (Thailand) Ltd.
Sankar Balasubramanian Ethics and Compliance Officer India, GSK
Vinayak Bindal Sub-Regional Compliance Officer, S outh East Asia, Merck Pte. Ltd. Singapore
Saovapa T. Chutrakul Legal Director & North Asia Cluster Lead, Pfizer (Thailand) Ltd.
Sineenard Deesamut Compliance Manager, Boehringer Ingelheim (Thai) Ltd
Nitika Garg Director - Research, Organisation of Pharmaceutical Producers of India (OPPI)
Sarinthip Jarunsathianchai Healthcare Compliance Officer Thailand, Laos, Cambodia & Myanmar, Johnson & Johnson (Thailand) Ltd.
Bussakorn Mahakkanukrauh Medical Affairs Manager, GSK
Orapin Panacharas Head of Ethics & Compliance Thailand, Takeda
Areeya Pornwiriyangkura Associated Director, Local Lead of Ethics & Compliance, Astellas Pharma (Thailand) co., Ltd
Sachin Salian Health Care Compliance Officer Janssen India and South Asia, Johnson & Johnson
Sherita Septiani Ethics and Compliance Officer Emerging Markets East, GSK
Naparlai Tangsanakun Compliance Counsel, Bayer Thai co., Ltd.
Ratanaporn Thangthanakul HR Development Manager/ Compliance Manager, Eisai (Thailand) Marketing co., Ltd.
Thannicha Vorawatjirapark Ethics and Compliance Officer, Eli Lilly Asia Inc. Thailand Branch
Holger Diener Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Germany and Vice-Chair of the Ethics and Business Integrity Committee of IFPMA
Karen Eryou Head, Ethics and Compliance Programs, UCB Pharma, Belgium Chair Code Capacity Working Group IFPMA
Sofie Melis Head of Ethics & Compliance, IFPMA, Switzerland
Hannes Oswald- Brügel Head Pharma Healthcare Compliance Office, Roche, Switzerland
Christian Roth Co-President IPCAA (International Pharmaceutical Congress Advisory Association)
Kiko Tranquilino Consultant on Ethics Matters, Pharmaceutical & Healthcare Association of the Philippines, Inc. (PHAP)


Supporting documents